patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
BYOOVIZ
Marketedupdated 2mo agoby Samsung Bioepis Co Ltd
Approvedcommunity read0 votes
all catalysts(8)
approval · 8
Sep 17, 2021
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Jun 9, 2022
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Aug 15, 2022
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Jun 16, 2023
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Oct 3, 2023
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Aug 15, 2025
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Nov 12, 2025
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
Mar 30, 2026
approval
BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approval
BYOOVIZ
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that